Annual FCF
-$145.37 M
-$52.85 M-57.12%
31 December 2023
Summary:
Akero Therapeutics annual free cash flow is currently -$145.37 million, with the most recent change of -$52.85 million (-57.12%) on 31 December 2023. During the last 3 years, it has fallen by -$65.69 million (-82.44%). AKRO annual FCF is now -1410.31% below its all-time high of -$9.63 million, reached on 31 December 2018.AKRO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$70.42 M
-$11.97 M-20.48%
30 September 2024
Summary:
Akero Therapeutics quarterly free cash flow is currently -$70.42 million, with the most recent change of -$11.97 million (-20.48%) on 30 September 2024. Over the past year, it has dropped by -$21.80 million (-44.82%). AKRO quarterly FCF is now -20735.50% below its all-time high of -$338.00 thousand, reached on 31 March 2018.AKRO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$212.64 M
-$20.70 M-10.79%
30 September 2024
Summary:
Akero Therapeutics TTM free cash flow is currently -$212.64 million, with the most recent change of -$20.70 million (-10.79%) on 30 September 2024. Over the past year, it has dropped by -$67.28 million (-46.28%). AKRO TTM FCF is now -62812.13% below its all-time high of -$338.00 thousand, reached on 31 March 2018.AKRO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -44.8% | -46.3% |
| 3 y3 years | -82.4% | -163.8% | -166.9% |
| 5 y5 years | -308.0% | -504.6% | -496.9% |
AKRO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.4% | at low | -261.0% | at low | -166.9% | at low |
| 5 y | 5 years | -308.0% | at low | -522.3% | at low | -496.9% | at low |
| alltime | all time | -1410.3% | at low | <-9999.0% | at low | <-9999.0% | at low |
Akero Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$70.42 M(+20.5%) | -$212.64 M(+10.8%) |
| June 2024 | - | -$58.45 M(+66.3%) | -$191.94 M(+23.1%) |
| Mar 2024 | - | -$35.14 M(-27.7%) | -$155.88 M(+7.2%) |
| Dec 2023 | -$145.37 M(+57.1%) | -$48.63 M(-2.2%) | -$145.37 M(+18.9%) |
| Sept 2023 | - | -$49.72 M(+122.1%) | -$122.25 M(+25.8%) |
| June 2023 | - | -$22.39 M(-9.1%) | -$97.15 M(+3.1%) |
| Mar 2023 | - | -$24.63 M(-3.4%) | -$94.27 M(+1.9%) |
| Dec 2022 | -$92.52 M(+16.1%) | -$25.51 M(+3.6%) | -$92.52 M(-1.3%) |
| Sept 2022 | - | -$24.62 M(+26.2%) | -$93.70 M(+12.0%) |
| June 2022 | - | -$19.51 M(-14.7%) | -$83.69 M(-0.6%) |
| Mar 2022 | - | -$22.88 M(-14.3%) | -$84.21 M(+5.7%) |
| Dec 2021 | -$79.68 M | -$26.70 M(+82.8%) | -$79.68 M(+4.3%) |
| Sept 2021 | - | -$14.61 M(-27.1%) | -$76.39 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$20.03 M(+9.2%) | -$75.43 M(-3.3%) |
| Mar 2021 | - | -$18.35 M(-21.6%) | -$77.98 M(+9.9%) |
| Dec 2020 | -$70.95 M(+99.2%) | -$23.40 M(+71.4%) | -$70.95 M(+19.8%) |
| Sept 2020 | - | -$13.65 M(-39.6%) | -$59.20 M(+0.7%) |
| June 2020 | - | -$22.58 M(+99.6%) | -$58.76 M(+41.6%) |
| Mar 2020 | - | -$11.32 M(-2.9%) | -$41.50 M(+16.5%) |
| Dec 2019 | -$35.63 M(+270.2%) | -$11.65 M(-11.8%) | -$35.63 M(+36.7%) |
| Sept 2019 | - | -$13.21 M(+148.3%) | -$26.05 M(+76.0%) |
| June 2019 | - | -$5.32 M(-2.2%) | -$14.80 M(+0.5%) |
| Mar 2019 | - | -$5.44 M(+162.4%) | -$14.73 M(+53.0%) |
| Dec 2018 | -$9.63 M | -$2.08 M(+5.8%) | -$9.63 M(+27.5%) |
| Sept 2018 | - | -$1.96 M(-62.7%) | -$7.55 M(+35.1%) |
| June 2018 | - | -$5.25 M(+1453.6%) | -$5.59 M(+1553.6%) |
| Mar 2018 | - | -$338.00 K | -$338.00 K |
FAQ
- What is Akero Therapeutics annual free cash flow?
- What is the all time high annual FCF for Akero Therapeutics?
- What is Akero Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Akero Therapeutics?
- What is Akero Therapeutics quarterly FCF year-on-year change?
- What is Akero Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Akero Therapeutics?
- What is Akero Therapeutics TTM FCF year-on-year change?
What is Akero Therapeutics annual free cash flow?
The current annual FCF of AKRO is -$145.37 M
What is the all time high annual FCF for Akero Therapeutics?
Akero Therapeutics all-time high annual free cash flow is -$9.63 M
What is Akero Therapeutics quarterly free cash flow?
The current quarterly FCF of AKRO is -$70.42 M
What is the all time high quarterly FCF for Akero Therapeutics?
Akero Therapeutics all-time high quarterly free cash flow is -$338.00 K
What is Akero Therapeutics quarterly FCF year-on-year change?
Over the past year, AKRO quarterly free cash flow has changed by -$21.80 M (-44.82%)
What is Akero Therapeutics TTM free cash flow?
The current TTM FCF of AKRO is -$212.64 M
What is the all time high TTM FCF for Akero Therapeutics?
Akero Therapeutics all-time high TTM free cash flow is -$338.00 K
What is Akero Therapeutics TTM FCF year-on-year change?
Over the past year, AKRO TTM free cash flow has changed by -$67.28 M (-46.28%)